Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 5, 2012, Pages 567-571

  Yonova Doing, Ekaterina ^a   Atadzhanov, Masharip ^b   Quadri, Marialuisa ^a   Kelly, Paul ^b   Shawa, Nyambura ^b   Musonda, Sheila T S ^b   Simons, Erik J ^a   Breedveld, Guido J ^a   Oostra, Ben A ^a   Bonifati, Vincenzo ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ZAMBIA   (Zambia)

Author keywords

DJ 1; Genetics; LRRK2; Parkin; Parkinson's disease; PINK1; SNCA; Zambia

Indexed keywords

DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PARKIN;

ADULT; AFRICAN; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DJ 1 GENE; ETHNIC GROUP; EXON; FEMALE; GENE DELETION; GENE PRODUCT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOTE DETECTION; HUMAN; INDIGENOUS PEOPLE; LLRK2 GENE; MALE; MISSENSE MUTATION; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKIN GENE; PARKINSON DISEASE; PINK1 GENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SNCA GENE; ZAMBIA; ZAMBIAN;

ADULT; ALPHA-SYNUCLEIN; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; UBIQUITIN-PROTEIN LIGASES; ZAMBIA;

EID: 84861189479     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.02.018     Document Type: Article

References (21)

1. Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med 2009, 11:e22.
2. Nalls M.A. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. International Parkinson Disease Genomics Consortium. Lancet 2011, 377:641-649.
3. Bonifati V. LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-Linking familial and sporadic Parkinson's disease. Neurochem Res 2007, 32:1700-1708.
4. Healy D.G., Falchi M., O'Sullivan S.S., Bonifati V., Durr A., Bressman S., et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008, 7:583-590.
5. Correia Guedes L., Ferreira J.J., Rosa M.M., Coelho M., Bonifati V., Sampaio C. Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2010, 16(4):237-242.
6. Atadzhanov M., Birbeck G. Race and ethnicity in Parkinson's disease. Genetic and prevalence data. New research on Parkinson's disease 2008, 59-108. Nova Science Publishers, Inc, New York. T.F. Hann, J. Werner (Eds.).
7. Atadzhanov M., Zumla A., Mwaba P. Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia. Postgrad Med J 2005, 81(952):117-121.
8. Okubadejo N.U. An analysis of genetic studies of Parkinson's disease in Africa. Parkinsonism Relat Disord 2008, 14(3):177-182.
9. Tishkoff S.A., Reed F.A., Friedlaender F.R., Ehret C., Ranciaro A., Froment A., et al. The genetic structure and history of Africans and African Americans. Science 2009, 324:1035-1044.
10. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56(1):33-39.
11. Keyser R.J., Lombard D., Veikondis R., Carr J., Bardien S. Analysis of exon dosage using MLPA in South African Parkinson's disease patients. Neurogenetics 2010, 11(3):305-312.
12. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003, 157(11):1015-1022.
13. Dahodwala N., Siderowf A., Xie M., Noll E., Stern M., Mandell D.S. Racial differences in the diagnosis of Parkinson's disease. Mov Disord 2009, 24(8):1200-1205.
14. Okubadejo N., Britton A., Crews C., Akinyemi R., Hardy J., Singleton A., et al. Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3. PLoS One 2008, 3(10):e3421.
15. Bardien S., Keyser R., Yako Y., Lombard D., Carr J. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. Parkinsonism Relat Disord 2009, 15(2):116-121.
16. Keyser R.J., Lesage S., Brice A., Carr J., Bardien S. Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson's disease. Biochem Biophys Res Commun 2011, 398(1):125-129.
17. Haylett W.L., Keyser R.J., du Plessis M.C., van der Merwe C., Blanckenberg J., Lombard D., et al. Mutations in the parkin gene are a minor cause of Parkinson's disease in the South African population. Parkinsonism Relat Disord 2012, 18(1):89-92.
18. Bardien S., Marsberg A., Keyser R., Lombard D., Lesage S., Brice A., et al. LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients. J Neural Transm 2010, 117(7):847-853.
19. Ross O.A., Wilhoite G.J., Bacon J.A., Soto-Ortolaza A., Kachergus J., Cobb S.A., et al. LRRK2 variation and Parkinson's disease in African Americans. Mov Disord 2010, 25(12):1973-1976.
20. Cilia R., Sironi F., Akpalu A., Cham M., Sarfo F.S., Brambilla T., et al. Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana. J Neurol Aug 14 2011, [Epub ahead of print].
21. Lohmann E., Periquet M., Bonifati V., Wood N.W., De Michele G., Bonnet A.M., et al. How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol 2003, 54(2):176-185.